Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferasirox PK and Safety in Chinese Pediatric Beta-Thalassemia
NCT01724138Phase 4Withdrawn
- Sponsor
- Novartis
- Start
- Jun 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of deferasirox in beta thalassemia, sponsored by Novartis. Planned start Jun 2013; status: withdrawn.
02
Drugs
deferasirox
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on NCT01724138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01724138.